1
|
Furukawa R, Kitabatake M, Ouji-Sageshima N, Tomita D, Kumamoto M, Suzuki Y, Nakano A, Nakano R, Matsumura Y, Kayano SI, Yano H, Tamaki S, Ito T. Antiviral Effect of Candies Containing Persimmon-Derived Tannin against SARS-CoV-2 Delta Strain. Viruses 2023; 15:1636. [PMID: 37631980 PMCID: PMC10459621 DOI: 10.3390/v15081636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 07/25/2023] [Accepted: 07/26/2023] [Indexed: 08/27/2023] Open
Abstract
Inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the mouth has the potential to reduce the spread of coronavirus disease 2019 (COVID-19), due to the virus being readily transmitted by dispersed saliva. Persimmon-derived tannin has strong antioxidant and antimicrobial activity owing to its strong adhesion to proteins, and it also exhibited antiviral effects against non-variant and Alpha-variant SARS-CoV-2 in our previous study. In this study, we first demonstrated the antiviral effects of persimmon-derived tannin against the Delta variant of SARS-CoV-2 in vitro via the plaque assay method. We then examined the effects of candy containing persimmon-derived tannin. Remarkably, the saliva samples provided by healthy volunteers while they were eating tannin-containing candy showed that the virus titers of the SARS-CoV-2 Delta variant were suppressed. In addition, we found that the SARS-CoV-2 viral load in saliva from patients with COVID-19 collected immediately after they had eaten the tannin-containing candy was below the level of detection via PCR for SARS-CoV-2. These data suggest that adding persimmon-derived tannin to candy and holding such candy in the mouth is an effective method for inactivating SARS-CoV-2 in saliva, and the application of this approach shows potential for inhibiting the transmission of COVID-19.
Collapse
Affiliation(s)
- Ryutaro Furukawa
- Department of Immunology, Nara Medical University, Kashihara 6348521, Japan; (R.F.); (M.K.); (N.O.-S.); (Y.M.)
| | - Masahiro Kitabatake
- Department of Immunology, Nara Medical University, Kashihara 6348521, Japan; (R.F.); (M.K.); (N.O.-S.); (Y.M.)
| | - Noriko Ouji-Sageshima
- Department of Immunology, Nara Medical University, Kashihara 6348521, Japan; (R.F.); (M.K.); (N.O.-S.); (Y.M.)
| | - Dai Tomita
- Department of Respiratory & Internal Medicine, National Hospital Organization Nara Medical Center, Nara 6308053, Japan; (D.T.); (M.K.); (S.T.)
| | - Makiko Kumamoto
- Department of Respiratory & Internal Medicine, National Hospital Organization Nara Medical Center, Nara 6308053, Japan; (D.T.); (M.K.); (S.T.)
| | - Yuki Suzuki
- Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara 6348521, Japan; (Y.S.); (A.N.); (R.N.); (H.Y.)
| | - Akiyo Nakano
- Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara 6348521, Japan; (Y.S.); (A.N.); (R.N.); (H.Y.)
| | - Ryuichi Nakano
- Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara 6348521, Japan; (Y.S.); (A.N.); (R.N.); (H.Y.)
| | - Yoko Matsumura
- Department of Immunology, Nara Medical University, Kashihara 6348521, Japan; (R.F.); (M.K.); (N.O.-S.); (Y.M.)
- Department of Health and Nutrition, Faculty of Health Science, Kio University, Koryo 6350832, Japan;
| | - Shin-ichi Kayano
- Department of Health and Nutrition, Faculty of Health Science, Kio University, Koryo 6350832, Japan;
| | - Hisakazu Yano
- Department of Microbiology and Infectious Diseases, Nara Medical University, Kashihara 6348521, Japan; (Y.S.); (A.N.); (R.N.); (H.Y.)
- MBT (Medicine-Based Town) Institute, Nara Medical University, Kashihara 6348521, Japan
| | - Shinji Tamaki
- Department of Respiratory & Internal Medicine, National Hospital Organization Nara Medical Center, Nara 6308053, Japan; (D.T.); (M.K.); (S.T.)
| | - Toshihiro Ito
- Department of Immunology, Nara Medical University, Kashihara 6348521, Japan; (R.F.); (M.K.); (N.O.-S.); (Y.M.)
- MBT (Medicine-Based Town) Institute, Nara Medical University, Kashihara 6348521, Japan
| |
Collapse
|
2
|
Kikuchi D, Ariyoshi D, Suzuki Y, Ochiai Y, Odagiri H, Hayasaka J, Tanaka M, Morishima T, Kimura K, Ezawa H, Nakagawa S, Iwamoto R, Matsuwaki Y, Hoteya S. Shielding device for endoscopic procedures during lower gastrointestinal endoscopy. DEN Open 2022; 3:e173. [PMID: 36247315 PMCID: PMC9549874 DOI: 10.1002/deo2.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 09/12/2022] [Accepted: 09/18/2022] [Indexed: 11/06/2022]
Abstract
Objectives The coronavirus pandemic significantly impacted endoscopic practice. During lower gastrointestinal endoscopy, infectious substances disseminate; therefore, we developed an infection control device (STEP‐L) for lower gastrointestinal endoscopy and examined its usefulness. Methods STEP‐L wraps around the patient's buttocks and covers the endoscope. Using lower endoscopy training models, three endoscopists performed 18 colonoscopies with STEP‐L (group S) and without (group C). Endoscopic insertion time and pigmented areas of gloves and diapers after the examination were compared between both groups. Results Insertion of the endoscope up to the cecum was possible in all 18 examinations. The insertion time to the cecum was 52.4 ± 19.0 s in group S and 53.9 ± 13.3 s in group C. The pigmented areas of the gloves measured 39,108.0 ± 16,155.3 pixels in group C, but were significantly reduced to 2610.5 ± 4333.8 pixels in group S (p < 0.05). The pigmented areas of the diapers measured 2280.9 ± 3285.2 pixels in group C, but were significantly reduced to 138.0 ± 82.9 pixels in group S (p < 0.05). Conclusions Using STEP‐L does not change the insertion time, and is technically feasible. STEP‐L significantly reduces the adhesion of virtual pollutants to the surroundings, suggesting that this device is useful for infection control during lower gastrointestinal endoscopy.
Collapse
Affiliation(s)
| | | | - Yugo Suzuki
- Department of GastroenterologyToranomon HospitalTokyoJapan
| | | | | | | | - Masami Tanaka
- Department of GastroenterologyToranomon HospitalTokyoJapan
| | | | | | | | | | | | | | - Shu Hoteya
- Department of GastroenterologyToranomon HospitalTokyoJapan
| |
Collapse
|
3
|
Abstract
Coxiella burnetii is an obligate intracellular bacterium that causes the human disease Q fever, which can manifest as an acute flu-like illness or a long-term chronic illness, such as endocarditis. Three genotypes (ST8, ST16, and ST20) of Coxiella burnetii are commonly found in the contemporary US and are associated with specific animal hosts. Although all three genotypes have been isolated from humans with Q fever, studies comparing virulence between C. burnetii sequence types have been rare. Here, groups of mice were infected via aerosol inoculation with isolates derived from cow's milk, environmental, animal, and human samples. Mice were monitored for weight loss and blood samples were takenweekly. Animals were euthanized at 2- and 12-weeks post-infection, and bacterial burden was determined for tissues by real-time PCR. The levels of anti-Coxiella antibodies and selected inflammatory cytokines were determined for serum samples. Weight loss and splenomegaly were observed in mice infected with ST20 and ST16 isolates but were absent in the mice infected with ST8 isolates. Bacterial concentrations in the tissues were lower in the ST8 isolates at 2 weeks post-infection relative to all other isolates. ST16 and ST20 isolates induced robust antibody and cytokine responses, while ST8 isolates produced significantly lower anti-C. burnetii titers early in the infection but saw increased titers in some animals several weeks post-infection. The data suggest that the ST8 isolates are less virulent in this mouse model, as they produce less robust antibody responses that are slow to develop, relative to the ST16 and ST20 isolates.
Collapse
Affiliation(s)
- Rachael A Priestley
- Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, United States
| | - Cody B Smith
- Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, United States
| | - Halie K Miller
- Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, United States
| | - Gilbert J Kersh
- Rickettsial Zoonoses Branch, Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Atlanta, United States
| |
Collapse
|
4
|
Pei J, Ding X, Fan Y, Rice-Ficht A, Ficht TA. Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice. Front Cell Infect Microbiol 2012; 2:115. [PMID: 22973560 PMCID: PMC3435510 DOI: 10.3389/fcimb.2012.00115] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2012] [Accepted: 08/15/2012] [Indexed: 01/18/2023] Open
Abstract
Brucella spp. cause undulant fever in humans and brucellosis in variety of other animals. Both innate and adaptive immunity have been shown to be important in controlling Brucella infection. Toll-like receptors (TLRs) represent a group of pattern recognition receptors (PRRs) that play critical roles in the host innate immune response, as well as development of adaptive immunity. In the current report, we investigated the role of TLR signaling in the clearance of Brucella and development of adaptive immunity in TLR2(-/-), TLR4(-/-), or MyD88(-/-) mice following aerosol exposure to B. melitensis 16 M. Consistent with previous reports, MyD88 is required for efficient clearance of Brucella from all three organs (lung, spleen, and liver). The results reveal Th2-skewed immune responses in TLR2(-/-) mice late in infection and support a TLR2 requirement for efficient clearance of Brucella from the lungs, but not from the spleen or liver. Similarly, TLR4 is required for efficient clearance of Brucella from the lung, but exhibits a minor contribution to clearance from the spleen and no demonstrable contribution to clearance from the liver. Lymphocyte proliferation assays suggest that the TLRs are not involved in the development of cell-mediated memory response to Brucella antigen. Antibody detection reveals that TLR2 and 4 are required to generate early antigen-specific IgG, but not during the late stages of infection. TLR2 and 4 are only transiently required for IgM production and not at all for IgA production. In contrast, MyD88 is essential for antigen specific IgG production late in infection, but is not required for IgM generation over the course of infection. Surprisingly, despite the prominent role for MyD88 in clearance from all tissues, MyD88-knockout mice express significantly higher levels of serum IgA. These results confirm the important role of MyD88 in controlling infection in the spleen while providing evidence of a prominent contribution to protection in other tissues. In addition, although TLR4 and TLR2 contribute little to control of spleen infection, a significant contribution to clearance of lung infection is described.
Collapse
Affiliation(s)
- Jianwu Pei
- Department of Veterinary Pathobiology, Texas A&M University, College Station TX, USA.
| | | | | | | | | |
Collapse
|